Related Experiment Video
Updated: Jul 3, 2026

08:46
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
[Vaccination and development in sub-Saharian Africa]
1Société de pathologie exotique, 25, rue du Dr Roux, 75724 Paris cedex 15.
Bulletin De L'Academie Nationale De Medecine
|August 1, 2008
Summary
Addressing public health issues like infant mortality through vaccination is vital for African economic development. The Expanded Program of Immunization (EPI) has shown success, with recent efforts reversing coverage declines.
Area of Science:
- Public Health
- Epidemiology
- Global Health
Context:
- African economic development is intrinsically linked to public health improvements.
- Infant mortality rates serve as a key indicator of population health.
- Infectious diseases account for over 60% of infant deaths in Africa, highlighting the critical role of vaccination.
Purpose:
- To analyze the impact of public health initiatives, specifically vaccination programs, on African economic development.
- To examine the historical trends and challenges of the Expanded Program of Immunization (EPI) in Africa.
- To assess recent progress and future outlook for vaccination coverage and its role in improving child survival rates.
Summary:
- The Expanded Program of Immunization (EPI), established in 1974, has significantly reduced infant mortality by increasing vaccine coverage for diseases like tuberculosis, diphtheria, tetanus, pertussis, poliomyelitis, measles, yellow fever, and hepatitis B.
- Vaccine coverage saw rapid growth until the early 1990s but subsequently declined due to financial, sociopolitical, and supply chain issues.
- Since 2000, a partial reversal of this decline has been observed, driven by initiatives like GAVI and the growth of domestic vaccine industries, improving the outlook for child health in Africa.
Impact:
- Effective vaccination programs are essential for reducing infant mortality and fostering sustainable economic growth in Africa.
- The EPI has demonstrably saved lives and improved overall population health, contributing to socio-economic progress.
- Continued investment and innovation in vaccine access and delivery are crucial for overcoming persistent public health challenges and realizing Africa's development potential.
Related Concept Videos
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations
Overview
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...

